Ceapro Inc. | Balance Sheet

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,953.00
272.80
1,681.10
9,150.00
6,173.90
1,844.10
Total Accounts Receivable
530.30
634.50
663.10
688.40
1,459.90
3,062.20
Inventories
323.60
679.30
1,242.40
1,183.40
1,085.40
710.70
Other Current Assets
342.30
61.50
259.60
372.00
277.60
518.20
Total Current Assets
3,149.20
1,648.10
3,846.20
11,393.80
8,996.80
6,135.30
Net Property, Plant & Equipment
1,853.00
5,962.00
9,868.70
14,324.90
17,379.80
17,948
Long-Term Note Receivable
-
-
603.30
-
-
-
Intangible Assets
66.30
36.30
33.30
30.40
735.70
24.40
Other Assets
28.60
36.90
93.30
578.30
695.50
696
Total Assets
5,097.00
7,683.20
15,703.50
26,391.60
27,807.90
25,324.60
ST Debt & Current Portion LT Debt
679.40
768.30
1,929.60
1,075.20
933.80
Accounts Payable
994.40
1,707.30
1,875.30
819.20
979.60
Income Tax Payable
-
-
95.20
-
-
Other Current Liabilities
538.90
489.20
1,302.50
639.60
2,153.60
Total Current Liabilities
2,212.70
2,964.80
5,202.60
2,534.00
4,067.10
Long-Term Debt
2,512.80
2,361.30
2,618.90
1,456.90
592.00
Provision for Risks & Charges
127.00
-
-
-
-
Deferred Taxes
-
-
1,147.10
64.20
604.80
Other Liabilities
-
265.10
-
-
-
Total Liabilities
4,852.50
5,591.20
7,933.10
3,990.90
5,264.00
Common Equity (Total)
244.50
2,092.00
7,770.30
22,400.70
22,543.90
Total Shareholders' Equity
244.50
2,092.00
7,770.30
22,400.70
22,543.90
Total Equity
244.50
2,092.00
7,770.30
22,400.70
22,543.90
Liabilities & Shareholders' Equity
5,097.00
7,683.20
15,703.50
26,391.60
27,807.90

About Ceapro

View Profile
Address
7824-51 Avenue NW
Edmonton Alberta T6E 6W2
Canada
Employees -
Website http://www.ceapro.com
Updated 07/08/2019
Ceapro, Inc. is a biotechnology company, which is involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its extracts are also used in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company specializes in natural product chemistry, microbiology, biochemistry, immunology, and process engineering in the fields of active ingredients, biopharmaceuticals, and drug-delivery solutions.